UK Prospective Diabetes Study (UKPDS) Group.Effects of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). Lancet1998;352:854-65.
2.
Jones GC, Macklin JP, Alexander WDContraindications to the use of metformin. BMJ2003;326:4-5.
3.
Tattersall RBFrequency, causes and treatment of hypoglycaemia. In: Frier BM and Fisher BM (eds), Hypoglycaemia in clinical diabetes. 1999. Chichester: Wiley and Sons : pp 55-87.
4.
Salpeter S., Greyber E., Pasternak G., Salpeter E.Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). Cochrane Database Syst Rev2003;(2):CD002967.
5.
Howlett HCS , Bailey CJA risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety1999 ;20:489-503.
6.
Seltzer HSDrug-induced hypoglycaemia. A review of 1418 cases. Endocrinol Metab Clin North Am1989;18(1):163-83.
